JPS58189186A - セフアロスポリン誘導体 - Google Patents

セフアロスポリン誘導体

Info

Publication number
JPS58189186A
JPS58189186A JP57073729A JP7372982A JPS58189186A JP S58189186 A JPS58189186 A JP S58189186A JP 57073729 A JP57073729 A JP 57073729A JP 7372982 A JP7372982 A JP 7372982A JP S58189186 A JPS58189186 A JP S58189186A
Authority
JP
Japan
Prior art keywords
compound
acid
same manner
methyl
title compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57073729A
Other languages
English (en)
Japanese (ja)
Inventor
Yoshinobu Yoshimura
義信 吉村
Sunao Hamaguchi
直 濱口
Koji Yashiki
矢敷　孝司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP57073729A priority Critical patent/JPS58189186A/ja
Priority to CA000425860A priority patent/CA1215971A/en
Priority to US06/486,820 priority patent/US4497809A/en
Priority to DE8383302280T priority patent/DE3368638D1/de
Priority to EP83302280A priority patent/EP0093548B1/en
Priority to GR71196A priority patent/GR78545B/el
Priority to ES521955A priority patent/ES8406492A1/es
Priority to PT76622A priority patent/PT76622B/pt
Priority to KR1019830001845A priority patent/KR840004757A/ko
Publication of JPS58189186A publication Critical patent/JPS58189186A/ja
Priority to ES528165A priority patent/ES528165A0/es
Priority to ES528166A priority patent/ES8506318A1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57073729A 1982-04-30 1982-04-30 セフアロスポリン誘導体 Pending JPS58189186A (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP57073729A JPS58189186A (ja) 1982-04-30 1982-04-30 セフアロスポリン誘導体
CA000425860A CA1215971A (en) 1982-04-30 1983-04-14 Cephalosporin derivatives
US06/486,820 US4497809A (en) 1982-04-30 1983-04-20 Cephalosporin derivatives
DE8383302280T DE3368638D1 (en) 1982-04-30 1983-04-21 Cephalosporin derivatives
EP83302280A EP0093548B1 (en) 1982-04-30 1983-04-21 Cephalosporin derivatives
GR71196A GR78545B (enExample) 1982-04-30 1983-04-25
ES521955A ES8406492A1 (es) 1982-04-30 1983-04-29 Un procedimiento para preparar derivados de cefalosporina.
PT76622A PT76622B (en) 1982-04-30 1983-04-29 Cephalosporin derivatives
KR1019830001845A KR840004757A (ko) 1982-04-30 1983-04-30 세파로스포린 유도체의 제조방법
ES528165A ES528165A0 (es) 1982-04-30 1983-12-19 Un procedimiento para preparar derivados de cefalosporina
ES528166A ES8506318A1 (es) 1982-04-30 1983-12-19 Un procedimiento para preparar derivados de cefalosporina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57073729A JPS58189186A (ja) 1982-04-30 1982-04-30 セフアロスポリン誘導体

Publications (1)

Publication Number Publication Date
JPS58189186A true JPS58189186A (ja) 1983-11-04

Family

ID=13526607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57073729A Pending JPS58189186A (ja) 1982-04-30 1982-04-30 セフアロスポリン誘導体

Country Status (9)

Country Link
US (1) US4497809A (enExample)
EP (1) EP0093548B1 (enExample)
JP (1) JPS58189186A (enExample)
KR (1) KR840004757A (enExample)
CA (1) CA1215971A (enExample)
DE (1) DE3368638D1 (enExample)
ES (3) ES8406492A1 (enExample)
GR (1) GR78545B (enExample)
PT (1) PT76622B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5989691A (ja) * 1982-11-15 1984-05-23 Takeda Chem Ind Ltd セフアロスポリンエステル
CA1215354A (en) * 1983-06-02 1986-12-16 Akio Miyake Cephalosporin esters, their production and use
NZ208281A (en) * 1983-06-02 1986-11-12 Takeda Chemical Industries Ltd Cephalosporin ester derivatives and pharmaceutical compositions
JPS59225191A (ja) * 1983-06-02 1984-12-18 Takeda Chem Ind Ltd 経口用セフアロスポリン誘導体
JPS6038387A (ja) * 1983-08-10 1985-02-27 Takeda Chem Ind Ltd セフアロスポリンエステル
JPS60224693A (ja) * 1984-04-20 1985-11-09 Takeda Chem Ind Ltd セフアロスポリンエステル誘導体
GB9001405D0 (en) * 1990-01-22 1990-03-21 Leo Pharm Prod Ltd New intermediates,their production and use
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS603314B2 (ja) * 1976-08-31 1985-01-26 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
JPS5777690A (en) * 1980-10-31 1982-05-15 Takeda Chem Ind Ltd Cephalosporin derivative

Also Published As

Publication number Publication date
EP0093548A2 (en) 1983-11-09
ES8506731A1 (es) 1985-07-16
GR78545B (enExample) 1984-09-27
PT76622B (en) 1986-01-17
KR840004757A (ko) 1984-10-24
ES528166A0 (es) 1985-07-01
PT76622A (en) 1983-05-01
ES528165A0 (es) 1985-07-16
ES521955A0 (es) 1984-07-01
EP0093548B1 (en) 1986-12-30
US4497809A (en) 1985-02-05
ES8406492A1 (es) 1984-07-01
CA1215971A (en) 1986-12-30
DE3368638D1 (en) 1987-02-05
ES8506318A1 (es) 1985-07-01
EP0093548A3 (en) 1984-10-10

Similar Documents

Publication Publication Date Title
US2802005A (en) S-eluorourace
BE897422A (fr) Nouvelle forme d'ester de cefuroxime, procede pour sa preparation et composition pharmaceutique la contenant
JPS58189186A (ja) セフアロスポリン誘導体
RU2162081C2 (ru) Способ получения ламотриджина и промежуточное соединение, используемое при его получении
JPS63132893A (ja) 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
JPS59148789A (ja) 高度に結晶性のナトリウムセフオペラゾンの製法
JPS603314B2 (ja) セフアロスポリン誘導体およびその製造法
US4880798A (en) Cephalosporin derivatives
CA1216285A (en) Cephalosporin ester derivatives, their production and use
JPS604189B2 (ja) 抗菌剤およびその製法
JPS6123197B2 (enExample)
CA1128499A (en) Crystalline salt of cephalosporin derivative
NO140269B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater
JPS55151588A (en) Preparation of cephalosporin salt crystal
JPS609757B2 (ja) 経口用セフアロスポリン化合物
US3507958A (en) Compositions and methods of treating bacteria with cyclopropyl-2-sulphanilamido-pyrimidines
JPH06503805A (ja) ペネム化合物
JPS6322570A (ja) １−メタンスルホニルオキシ−６−トリフルオロメチル−１ｈ−ベンゾトリアゾ−ル及びセファロスポリン誘導体の製造方法
JPS6038387A (ja) セフアロスポリンエステル
GB2070589A (en) 7a1methoxycephalospin derivatives
Montgomery et al. Studies of the Forms of Arabinose1
JPS59225191A (ja) 経口用セフアロスポリン誘導体
JPS6335580A (ja) 新規７−アミノ−３−複素環チオメチル−δ↑３−セフエム−４−カルボン酸類の製造法
US3966734A (en) Method for the purification of 6-methoxy-1-phenazinol 5,10-dioxide
JPS5857385A (ja) 水和物、その製造法および細菌感染症治療剤